Login / Signup
Lower probability of relapse after myeloablative cord blood transplantation for patients with refractory AML.
Andromachi Scaradavou
Jaap Jan Boelens
Published in:
British journal of haematology (2022)
Keyphrases
</>
cord blood
allogeneic hematopoietic stem cell transplantation
acute myeloid leukemia
stem cell transplantation
acute lymphoblastic leukemia
free survival
cell therapy
high dose
stem cells
low dose
mesenchymal stem cells